目的:扩增丙型肝炎病毒(Hepatitis Cvirus,HCV)P7蛋白基因,克隆到多个原核表达系统,观察P7蛋白在体外表达的情况,获取具有生物学活性的HCVP7重组蛋白。方法:设计扩增全长HCVP7基因片段的特异引物,以H/FL质粒DNA(含HCV1acDNA全长序列)为模板,通过PCR扩增全长HCV P7基因,定向克隆到pQE30、pGEX 4T-2、pET32a(+)3种不同类型的原核表达载体中。将重组后包含HCVP7基因的原核表达载体转化表达型大肠杆菌BL21(DE3)pLysS或SG13009(PREP4),并做异丙基硫化-β-D-半乳糖苷(Isopropyl-beta-D-thiogalactoside,IPTG)诱导表达,通过SDS-PAGE和Western blot鉴定HCV P7蛋白原核表达的情况。结论:获得可溶性的重组蛋白GST-HCVP7和Trx-HCVP7,为进一步研究P7蛋白的生物学功能奠定基础。
Objective: To amplify HCV P7 gene and clone it into several prokaryotic expression systems,then investigate the effects of these working systems and harvest HCV P7 protein with biologic activity.Methods: Design Special primers were designed for the amplification of HCV P7 complete DNA sequence and amplify P7 DNA fragments were amplified with H/FL plasmid as template by PCR.The obtained P7 DNA fragments were directly cloned into pQE30,pGEX 4T-2 and pET32a(+) prokaryotic expression vectors and transform these recombinant plasmids were transformed into E coli.strain BL21(DE3) pLysS or SG13009(PREP4),and IPTG was added to induce recombinant E coli.expression.The expression products were identified with SDS-PAGE and Western blot.Results: There was no track of non-fusion HCV P7 protein expression from recombinant E coli,including pQE30/HCV P7 or pET32a(+)-Nde/HCV P7 plasmid.But the study succeeded in the expression and purification of recombinant HCV P7 proteins,Both are all soluble and biologic activity,and are expected to use extensively in anti-HCV virus research.